Detalles de la búsqueda
1.
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Int J Clin Oncol
; 28(1): 79-88, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414827
2.
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
BMC Cancer
; 20(1): 115, 2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32046667
3.
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
BMC Cancer
; 18(1): 946, 2018 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285770
4.
The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.
Jpn J Clin Oncol
; 48(1): 89-93, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29036303
5.
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.
Cancer
; 122(7): 1050-9, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26828788
6.
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Cancer
; 119(12): 2275-81, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23558513
7.
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR).
Transl Lung Cancer Res
; 10(7): 3059-3070, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430347
8.
[I. What is the Standard Treatment of EGFR-TKIs? Did EGFR-TKIs Improve Treatment for Non-Small Cell Lung Cancer?].
Gan To Kagaku Ryoho
; 42(8): 931-4, 2015 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-26353389
9.
The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients.
Respir Investig
; 58(4): 269-274, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111518
10.
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Lung Cancer
; 128: 20-25, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642448
11.
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer.
Intern Med
; 57(9): 1269-1272, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29279482
12.
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
Lung Cancer
; 124: 65-70, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268482
13.
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug.
Med Oncol
; 24(1): 103-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17673819
14.
Usefulness of the oximetry test for the diagnosis of sleep apnea syndrome in Japan.
Am J Med Sci
; 331(6): 304-8, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16775436
15.
Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
Respir Investig
; 54(5): 334-40, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566381
16.
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.
J Clin Oncol
; 34(27): 3248-57, 2016 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27022112
17.
Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase.
Kobe J Med Sci
; 51(1-2): 17-27, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16199931
18.
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109).
Lung Cancer
; 87(2): 136-40, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25553650
19.
Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).
Anticancer Res
; 35(7): 3885-91, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26124334
20.
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
Cancer Chemother Pharmacol
; 75(6): 1267-72, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925001